结石康胶囊联合盐酸坦洛新缓释胶囊治疗慢性前列腺炎合并前列腺结石临床观察

目的探讨结石康胶囊联合盐酸坦洛新缓释胶囊治疗慢性前列腺炎合并前列腺结石的临床效果。方法选择2016年2月—2018年2月在医院进行治疗的慢性前列腺炎合并前列腺结石的患者80例,按照随机数字的方法将患者分为对照组与观察组各40例,对照组给予盐酸坦洛新缓释胶囊,观察组在对照组基础上给予结石康胶囊。对比两组治疗前后的慢性前列腺炎症状指数评分(NIH-CPSI),前列腺液中的白细胞计数,卵磷脂小体。对比两组的结石排出时间和结石排出率。对比两组的治疗效果。结果经过治疗后,两组患者慢性前列腺炎症状指数评分,前列腺液中的白细胞计数均降低,卵磷脂小体均增高(t=2.007,2.778,-2.027,7.614,10.046,-6.038,P<0.05),在治疗后的组间比较中,观察组的慢性前列腺炎症状指数评分,前列腺液中的白细胞计数低于对照组,卵磷脂小体高于对照组(t=6.313,10.235,-5.385,P<0.05),观察组的结石排出时间短于对照组,结石排出率高于对照组(t=5.655,χ~2=7.384,P<0.05),观察组的治疗效果优于对照组(z=-2.142,P<0.05),观察组的治疗总有效率高于对照组(χ~2=4.505,P<0.05)。结论使用结石康胶囊联合盐酸坦洛新缓释胶囊治疗慢性前列腺炎合并前列腺结石的患者,可以提升治疗效果,改善临床症状。

Clinical Observation on Jieshikang Capsule Combined with Tamsulosin Hydrochloride Sustained-Release Capsule Treating Chronic Prostatitis with Prostatic Stone

Objective To explore the clinical effect of Jieshikang Capsule combined with Tamsulosin Hydrochloride Sustained-Release Capsule in the treatment of chronic prostatitis complicated with prostatic stone.Methods Eighty patients with chronic prostatitis complicated with prostatic stone who were treated in the hospital between February 2016 and February 2018 were enrolled.Patients were divided into control group(n=40)and observation group(n=40)according to random numbers.The control group was given Tamsulosin Hydrochloride Sustained-Release Capsule and the observation group was given Jieshikang Capsule on the basis of the control group.The chronic prostatitis symptoms index score(NIH-CPSI)before and after treatment,white blood cell count in prostatic fluid,and lecithin bodies were compared.The stone discharge time and stone discharge rate were compared between the two groups.The therapeutic effects of the two groups were compared.Results After treatment,the scores of chronic prostatitis symptoms in the two groups,the white blood cell count in the prostatic fluid decreased,and the lecithin bodies increased(t=2.007,2.778,-2.027,7.614,10.046,-6.038,P<0.05).In the comparison between the groups after treatment,the chronic prostatitis symptoms index score of the observation group and the white blood cell count in the prostatic fluid were lower than those of the control group,and the lecithin body was higher than that of the control group(t=6.313,10.235,-5.385,P<0.05).The stone discharge time of the observation group was shorter than that of the control group,and the stone discharge rate was higher than that of the control group(t=5.655,χ~2=7.384,P<0.05).The therapeutic effect of the observation group was better than that of the control group(z=-2.142,P<0.05).The effective rate of treatment in the observation group was higher than that in the control group(χ~2=4.505,P<0.05).Conclusion The use of Jieshikang Capsule combined with Tamsulosin Hydrochloride Sustained-Release Capsule in the treatment of chronic prostatitis patients complicated with prostatic stone can improve the treatment effect and relieve clinical symptoms.